
The #lymphatic system: the new target for effective #decongestion in decompensated #HeartFailure ? academic.oup.com/eurjhf/adva… #EJHF @EJHFEiC @JanBiegus

MD PhD, Cardiology, Heart Failure and Intensive Cardiac Care. Wroclaw Medical University, Poland. #ESC Heart Failure Deputy Editor-in-Chief

The #lymphatic system: the new target for effective #decongestion in decompensated #HeartFailure ? academic.oup.com/eurjhf/adva… #EJHF @EJHFEiC @JanBiegus

We are proud to share our recent publication Heart Failure in Anthracycline Cardiotoxicity: From Mechanisms to Clinical Management academic.oup.com/eschf/artic…

🗞️ GDMT is associated with reduced loop diuretic requirements, whereas diuretic dose does not modify GDMT benefit in heart failure: #STRONG_HF @GiuseppeGalati_ @AmrAbdin10 @HanCardiomd bit.ly/3WKDYax x.com/EJHFEiC/status/2117304…

I highly recommend this short read! 🫡
🫀 The second universal definition of heart failure (2026): what's new?💡3 LVEF groups instead of 4, with no fixed cut-offs 💡First universal classification of HF aetiology (18 groups)💡Clear split between worsening HF and decompensated HF 💡Normal NPs should not end the HFpEF workup Viewpoint #ESCHeartFailure, open access 👇 ow.ly/bZcK50ZVIVO #HeartFailure #CardioTwitter @EJHFEiC @AmrAbdin10 @GiuseppeGalati_ @HanCardiomd @EJHFEiC @JanBiegus @ppponikowski #HFA_ESC @hvanspall @FudimMarat @gcfmd @MarcoMetra @GianluSava

Landmark clinical trials shaping contemporary guideline-directed medical therapy for heart failure see@ ow.ly/e1j750ZTnw6 @EJHFEiC @AmrAbdin10 @GiuseppeGalati_ @HanCardiomd @EJHFEiC @JanBiegus @ppponikowski #HFA_ESC @hvanspall @FudimMarat @gcfmd @MarcoMetra @GianluSava

⏳ DEADLINES EXTENDED | #CVCT2026 More time to bring your research to Washington, D.C. 🔬 Late-Breaking Clinical Trials NEW deadline: October 8 📊 Poster Presentations NEW deadline: October 15 Submit: globalcvctforum.com/ #CVCT #LBCT #Posters

LAST CALL | CVCT-LMIC Fellowship Join the global clinical trials community at #CVCT2026 in Washington, DC ✈️ Travel & accommodation covered 🎓 Registration waived 🤝 Mentorship, masterclasses & networking ⏳ Apply by October 8 here: globalcvctforum.com/wac-lmic… #LMIC #ClinicalTrials

💡New Evidence in Heart Failure: 2026 Update, see comprehensive UPDATE @ ow.ly/7YhP50ZRltV @EJHFEiC @AmrAbdin10 @GiuseppeGalati_ @HanCardiomd @EJHFEiC @JanBiegus @ppponikowski #HFA_ESC @hvanspall @FudimMarat @gcfmd @MarcoMetra @GianluSava

💡 Can we predict diuresis in decompensated HF? 💧DRC-AHF machine-learning model uses just 3 variables: eGFR, uNa & uCreatinine. 6-h urine output prediction: r=0.90 in an independent validation cohort. #HeartFailure #AI ow.ly/bn3q50ZQQBa @EJHFEiC @AmrAbdin10 @GiuseppeGalati_ @HanCardiomd @EJHFEiC @JanBiegus @ppponikowski #HFA_ESC @hvanspall @FudimMarat @gcfmd @MarcoMetra @GianluSava

Nasz zespół 👍💪
Instytut Chorób Serca@KatedraICHS Sep 22 ALT Nagroda Polskiego Towarzystwa Kardiologicznego dla naszego zespołu! Zespół naszego ośrodka, pod kierownictwem prof. Piotra Ponikowskiego i prof. Jana Biegusa, otrzymał Nagrodę Polskiego Towarzystwa Kardiologicznego za publikację naukową w roku 2025. Nagrodzona została praca opublikowana w European Journal of Heart Failure: „Sodium chloride versus glucose solute as a volume replacement therapy for more effective decongestion in acute heart failure (SOLVRED-AHF): A prospective, randomized, mechanistic study" Autorzy: Jan Biegus, Gracjan Iwanek, Jeffrey Testani, Robert Zymliński, Marat Fudim, Mateusz Guzik, Piotr Gajewski i Piotr Ponikowski. Co szczególnie dla nas ważne, badanie SOLVRED-AHF zostało przeprowadzone w całości w naszym ośrodku. To efekt pracy naszego zespołu nad poszukiwaniem skuteczniejszych sposobów leczenia przewodnienia u pacjentów z ostrą niewydolnością serca. #InstytutChoróbSerca #UMW #Kardiologia #HeartFailure #SOLVREDAHF #Nauka #BadaniaKliniczne #PTK


💡Anaemia and all-cause mortality in contemporary HFpEF: an updated systematic review and meta-analysis @ESC ow.ly/mQL550ZPol8 @EJHFEiC @AmrAbdin10 @GiuseppeGalati_ @HanCardiomd @EJHFEiC @JanBiegus @ppponikowski #HFA_ESC @hvanspall @FudimMarat @gcfmd @MarcoMetra @GianluSava

Generative AI & Autonomous Systems. Can we evaluate the unevaluable? At #CVCT2026, experts will discuss whether existing frameworks can truly assess Generative AI in clinical medicine, or whether we need to build new ones. Join us: globalcvctforum.com/scientif… #CVCT #AI

Timing-specific factors associated with early, intermediate, and late readmission after heart failure hospitalization see@ ow.ly/ivTa50ZMq7e @EJHFEiC @AmrAbdin10 @GiuseppeGalati_ @HanCardiomd @EJHFEiC @JanBiegus @ppponikowski #HFA_ESC @hvanspall @FudimMarat @gcfmd @MarcoMetra @GianluSava

Can device-based therapies help tackle the cardiorenal syndrome in acute heart failure? A new expert review introduces a practical mechanistic framework: 🔹 Pullers 🔹 Pushers 🔹 Removers see@ ow.ly/kFNJ50ZGnV5 @EJHFEiC @AmrAbdin10 @GiuseppeGalati_ @HanCardiomd @EJHFEiC @JanBiegus @ppponikowski #HFA_ESC @hvanspall @FudimMarat @gcfmd @MarcoMetra @GianluSava

Distinct prognostic trajectories of heart failure phenotypes following kidney transplantation. see #ESCHF ow.ly/xBsq50ZJcUL @EJHFEiC @AmrAbdin10 @GiuseppeGalati_ @HanCardiomd @EJHFEiC @JanBiegus @ppponikowski #HFA_ESC @hvanspall @FudimMarat @gcfmd @MarcoMetra @GianluSava